Semaglutide Use in Diabetes: A Doubling Risk of Irreversible Vision Loss
Semaglutide, a once-weekly medication widely used to manage Type 2 diabetes (T2D), has proven benefits in controlling blood sugar and promoting weight loss. However, a recent study published in the International Journal of Retina and Vitreous highlights a significant concern: its use may double the risk of developing nonarteritic anterior ischemic optic neuropathy (NAION)—a condition […]







